Department of Nutritional Sciences, University of Arizona, Tucson, AZ, USA.
Am J Clin Nutr. 2013 Jul;98(1):105-10. doi: 10.3945/ajcn.112.054445. Epub 2013 May 22.
The role of vitamin D in breast cancer prevention is equivocal. Saudi Arabian women may be at greater risk of vitamin D deficiency because of a darker skin type and a greater likelihood of reduced ultraviolet B radiation exposure. Data regarding the vitamin D status of Saudi Arabian women and its relation to breast cancer risk are lacking.
The purpose of this research was to evaluate the association between circulating concentrations of 25-hydroxyvitamin D [25(OH)D] and breast cancer risk in Saudi Arabian women.
A case-control study was conducted among 120 breast cancer cases and 120 controls. The study population was drawn from patients admitted to King Fahd Hospital in Jeddah, Saudi Arabia, from June to August 2009. Participants completed questionnaires on diet and medical history, and serum samples were collected from all women to measure circulating 25(OH)D concentrations.
The participants had a mean age of 47.8 y and a mean body mass index (BMI; in kg/m(2)) of 30.0. Breast cancer cases had significantly lower (mean ± SD) serum concentrations of 25(OH)D (9.4 ± 6.4 ng/mL) than did controls (15.4 ± 12.3 ng/mL; P = 0.001). In comparison with those in the highest category of vitamin D status for this population (≥20 ng/mL), the adjusted ORs (95% CIs) for invasive breast cancer were 6.1 (2.4, 15.1) for women with a serum 25(OH)D concentration <10 ng/mL and 4.0 (1.6, 10.4) for women with a serum concentration of ≥10 to <20 ng/mL (P-trend = 0.0001).
An inverse association exists between serum 25(OH)D concentrations and breast cancer risk in Saudi Arabian women. This trial was registered at clinicaltrials.gov as NCT01817231.
维生素 D 在预防乳腺癌方面的作用尚无定论。沙特阿拉伯女性由于皮肤较黑,且更有可能减少紫外线 B 辐射暴露,因此可能面临更大的维生素 D 缺乏风险。目前缺乏有关沙特阿拉伯女性维生素 D 状况及其与乳腺癌风险之间关系的数据。
本研究旨在评估沙特阿拉伯女性循环 25-羟维生素 D [25(OH)D] 浓度与乳腺癌风险之间的关系。
这是一项病例对照研究,纳入了 120 例乳腺癌病例和 120 例对照。研究人群来自 2009 年 6 月至 8 月在沙特阿拉伯吉达的法赫德国王医院就诊的患者。所有女性均完成了关于饮食和病史的调查问卷,并采集了血清样本以测量循环 25(OH)D 浓度。
参与者的平均年龄为 47.8 岁,平均体重指数(BMI;kg/m²)为 30.0。与对照组(15.4 ± 12.3 ng/mL;P = 0.001)相比,乳腺癌病例的血清 25(OH)D 浓度(9.4 ± 6.4 ng/mL)显著更低。与该人群维生素 D 状态最高类别(≥20 ng/mL)相比,血清 25(OH)D 浓度<10 ng/mL 的女性患浸润性乳腺癌的校正比值比(95%CI)为 6.1(2.4,15.1),血清浓度为 10 至<20 ng/mL 的女性为 4.0(1.6,10.4)(P 趋势=0.0001)。
在沙特阿拉伯女性中,血清 25(OH)D 浓度与乳腺癌风险呈负相关。本试验在 clinicaltrials.gov 注册,编号为 NCT01817231。